Global Antibody Drug Conjugates Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Antibody Drug Conjugates Contract Manufacturing market size was valued at USD 2909.1 million in 2023 and is forecast to a readjusted size of USD 9320.3 million by 2030 with a CAGR of 18.1% during review period.
ADCs are mainly composed of three parts: antibodies, linkers, and cytotoxic loads. They are a type of bioactive cytotoxic drugs that are linked to monoclonal antibodies through chemical bonds and use monoclonal antibodies as carriers to target and transport cytotoxic drugs to target cells. Complex that works. The design concept of ADC was first proposed by Paul Ehrlich in the early 20th century. In 2000, the U.S. Food and Drug Administration (FDA) approved the first ADC drug, Mylotarg® (gemtuzumab ozogamicin), for the treatment of acute myeloid myelopathy in adults. Leukemic cell lines, marking the beginning of the era of ADC-targeted cancer therapy.
Key global companies of Antibody Drug Conjugates Contract Manufacturing (ADC) include Lonza, Merck, Recipharm, Thermo Fisher, AbbVie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia. The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share. The largest player is Lonza Group. From the production side, the global players are mainly concentrated in North America and Europe. North America accounts for about 35% of the global market share. In terms of type, IgG1 dominates the global antibody drug conjugate contract manufacturing market. In terms of application, solid tumor applications account for more than half of the market.
The Global Info Research report includes an overview of the development of the Antibody Drug Conjugates Contract Manufacturing industry chain, the market status of Solid Tumors (IgG1, IgG4), Hematological Malignancies (IgG1, IgG4), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibody Drug Conjugates Contract Manufacturing.
Regionally, the report analyzes the Antibody Drug Conjugates Contract Manufacturing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibody Drug Conjugates Contract Manufacturing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antibody Drug Conjugates Contract Manufacturing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibody Drug Conjugates Contract Manufacturing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., IgG1, IgG4).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibody Drug Conjugates Contract Manufacturing market.
Regional Analysis: The report involves examining the Antibody Drug Conjugates Contract Manufacturing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibody Drug Conjugates Contract Manufacturing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antibody Drug Conjugates Contract Manufacturing:
Company Analysis: Report covers individual Antibody Drug Conjugates Contract Manufacturing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibody Drug Conjugates Contract Manufacturing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Solid Tumors, Hematological Malignancies).
Technology Analysis: Report covers specific technologies relevant to Antibody Drug Conjugates Contract Manufacturing. It assesses the current state, advancements, and potential future developments in Antibody Drug Conjugates Contract Manufacturing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibody Drug Conjugates Contract Manufacturing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antibody Drug Conjugates Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Antibody Drug Conjugates Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Drug Conjugates Contract Manufacturing, with revenue, gross margin and global market share of Antibody Drug Conjugates Contract Manufacturing from 2019 to 2024.
Chapter 3, the Antibody Drug Conjugates Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibody Drug Conjugates Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugates Contract Manufacturing.
Chapter 13, to describe Antibody Drug Conjugates Contract Manufacturing research findings and conclusion.
ADCs are mainly composed of three parts: antibodies, linkers, and cytotoxic loads. They are a type of bioactive cytotoxic drugs that are linked to monoclonal antibodies through chemical bonds and use monoclonal antibodies as carriers to target and transport cytotoxic drugs to target cells. Complex that works. The design concept of ADC was first proposed by Paul Ehrlich in the early 20th century. In 2000, the U.S. Food and Drug Administration (FDA) approved the first ADC drug, Mylotarg® (gemtuzumab ozogamicin), for the treatment of acute myeloid myelopathy in adults. Leukemic cell lines, marking the beginning of the era of ADC-targeted cancer therapy.
Key global companies of Antibody Drug Conjugates Contract Manufacturing (ADC) include Lonza, Merck, Recipharm, Thermo Fisher, AbbVie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia. The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share. The largest player is Lonza Group. From the production side, the global players are mainly concentrated in North America and Europe. North America accounts for about 35% of the global market share. In terms of type, IgG1 dominates the global antibody drug conjugate contract manufacturing market. In terms of application, solid tumor applications account for more than half of the market.
The Global Info Research report includes an overview of the development of the Antibody Drug Conjugates Contract Manufacturing industry chain, the market status of Solid Tumors (IgG1, IgG4), Hematological Malignancies (IgG1, IgG4), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibody Drug Conjugates Contract Manufacturing.
Regionally, the report analyzes the Antibody Drug Conjugates Contract Manufacturing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibody Drug Conjugates Contract Manufacturing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antibody Drug Conjugates Contract Manufacturing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibody Drug Conjugates Contract Manufacturing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., IgG1, IgG4).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibody Drug Conjugates Contract Manufacturing market.
Regional Analysis: The report involves examining the Antibody Drug Conjugates Contract Manufacturing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibody Drug Conjugates Contract Manufacturing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antibody Drug Conjugates Contract Manufacturing:
Company Analysis: Report covers individual Antibody Drug Conjugates Contract Manufacturing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibody Drug Conjugates Contract Manufacturing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Solid Tumors, Hematological Malignancies).
Technology Analysis: Report covers specific technologies relevant to Antibody Drug Conjugates Contract Manufacturing. It assesses the current state, advancements, and potential future developments in Antibody Drug Conjugates Contract Manufacturing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibody Drug Conjugates Contract Manufacturing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antibody Drug Conjugates Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- IgG1
- IgG4
- Solid Tumors
- Hematological Malignancies
- Lonza Group
- Merck KGaA
- Recipharm
- Thermo Fisher Scientific
- Abbvie
- Piramal Pharma Solutions
- Catalent
- Sterling Pharma Solutions
- Curia
- Novasep
- Ajinomoto Bio-Pharma Services
- BSP Pharmaceuticals
- Cerbios-Pharma
- Goodwin Biotechnology
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Antibody Drug Conjugates Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Drug Conjugates Contract Manufacturing, with revenue, gross margin and global market share of Antibody Drug Conjugates Contract Manufacturing from 2019 to 2024.
Chapter 3, the Antibody Drug Conjugates Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antibody Drug Conjugates Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Drug Conjugates Contract Manufacturing.
Chapter 13, to describe Antibody Drug Conjugates Contract Manufacturing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Antibody Drug Conjugates Contract Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibody Drug Conjugates Contract Manufacturing by Type
1.3.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type in 2023
1.3.3 IgG1
1.3.4 IgG4
1.4 Global Antibody Drug Conjugates Contract Manufacturing Market by Application
1.4.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Solid Tumors
1.4.3 Hematological Malignancies
1.5 Global Antibody Drug Conjugates Contract Manufacturing Market Size & Forecast
1.6 Global Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region, (2019-2030)
1.6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.6 South America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.1.4 Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.2.4 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Recipharm
2.3.1 Recipharm Details
2.3.2 Recipharm Major Business
2.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.3.4 Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Recipharm Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.4.4 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business
2.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.5.4 Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Abbvie Recent Developments and Future Plans
2.6 Piramal Pharma Solutions
2.6.1 Piramal Pharma Solutions Details
2.6.2 Piramal Pharma Solutions Major Business
2.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.6.4 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.7 Catalent
2.7.1 Catalent Details
2.7.2 Catalent Major Business
2.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.7.4 Catalent Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Catalent Recent Developments and Future Plans
2.8 Sterling Pharma Solutions
2.8.1 Sterling Pharma Solutions Details
2.8.2 Sterling Pharma Solutions Major Business
2.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.8.4 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sterling Pharma Solutions Recent Developments and Future Plans
2.9 Curia
2.9.1 Curia Details
2.9.2 Curia Major Business
2.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.9.4 Curia Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Curia Recent Developments and Future Plans
2.10 Novasep
2.10.1 Novasep Details
2.10.2 Novasep Major Business
2.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.10.4 Novasep Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Novasep Recent Developments and Future Plans
2.11 Ajinomoto Bio-Pharma Services
2.11.1 Ajinomoto Bio-Pharma Services Details
2.11.2 Ajinomoto Bio-Pharma Services Major Business
2.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.11.4 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
2.12 BSP Pharmaceuticals
2.12.1 BSP Pharmaceuticals Details
2.12.2 BSP Pharmaceuticals Major Business
2.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.12.4 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 BSP Pharmaceuticals Recent Developments and Future Plans
2.13 Cerbios-Pharma
2.13.1 Cerbios-Pharma Details
2.13.2 Cerbios-Pharma Major Business
2.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.13.4 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cerbios-Pharma Recent Developments and Future Plans
2.14 Goodwin Biotechnology
2.14.1 Goodwin Biotechnology Details
2.14.2 Goodwin Biotechnology Major Business
2.14.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.14.4 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Goodwin Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Antibody Drug Conjugates Contract Manufacturing by Company Revenue
3.2.2 Top 3 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2023
3.2.3 Top 6 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2023
3.3 Antibody Drug Conjugates Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Antibody Drug Conjugates Contract Manufacturing Market: Region Footprint
3.3.2 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2024)
5.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
6.2 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
6.3.2 United States Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
6.3.3 Canada Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
6.3.4 Mexico Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
7.2 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country
7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
7.3.2 Germany Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.3 France Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.5 Russia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.6 Italy Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2019-2030)
8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.3 Japan Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.4 South Korea Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.5 India Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.7 Australia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
9.2 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
9.3 South America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
9.3.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
9.3.2 Brazil Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
9.3.3 Argentina Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
10.3.2 Turkey Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
10.3.4 UAE Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Antibody Drug Conjugates Contract Manufacturing Market Drivers
11.2 Antibody Drug Conjugates Contract Manufacturing Market Restraints
11.3 Antibody Drug Conjugates Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antibody Drug Conjugates Contract Manufacturing Industry Chain
12.2 Antibody Drug Conjugates Contract Manufacturing Upstream Analysis
12.3 Antibody Drug Conjugates Contract Manufacturing Midstream Analysis
12.4 Antibody Drug Conjugates Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Antibody Drug Conjugates Contract Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibody Drug Conjugates Contract Manufacturing by Type
1.3.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type in 2023
1.3.3 IgG1
1.3.4 IgG4
1.4 Global Antibody Drug Conjugates Contract Manufacturing Market by Application
1.4.1 Overview: Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Solid Tumors
1.4.3 Hematological Malignancies
1.5 Global Antibody Drug Conjugates Contract Manufacturing Market Size & Forecast
1.6 Global Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region, (2019-2030)
1.6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.6 South America Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.1.4 Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.2.4 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Recipharm
2.3.1 Recipharm Details
2.3.2 Recipharm Major Business
2.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.3.4 Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Recipharm Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.4.4 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business
2.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.5.4 Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Abbvie Recent Developments and Future Plans
2.6 Piramal Pharma Solutions
2.6.1 Piramal Pharma Solutions Details
2.6.2 Piramal Pharma Solutions Major Business
2.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.6.4 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.7 Catalent
2.7.1 Catalent Details
2.7.2 Catalent Major Business
2.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.7.4 Catalent Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Catalent Recent Developments and Future Plans
2.8 Sterling Pharma Solutions
2.8.1 Sterling Pharma Solutions Details
2.8.2 Sterling Pharma Solutions Major Business
2.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.8.4 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sterling Pharma Solutions Recent Developments and Future Plans
2.9 Curia
2.9.1 Curia Details
2.9.2 Curia Major Business
2.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.9.4 Curia Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Curia Recent Developments and Future Plans
2.10 Novasep
2.10.1 Novasep Details
2.10.2 Novasep Major Business
2.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.10.4 Novasep Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Novasep Recent Developments and Future Plans
2.11 Ajinomoto Bio-Pharma Services
2.11.1 Ajinomoto Bio-Pharma Services Details
2.11.2 Ajinomoto Bio-Pharma Services Major Business
2.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.11.4 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
2.12 BSP Pharmaceuticals
2.12.1 BSP Pharmaceuticals Details
2.12.2 BSP Pharmaceuticals Major Business
2.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.12.4 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 BSP Pharmaceuticals Recent Developments and Future Plans
2.13 Cerbios-Pharma
2.13.1 Cerbios-Pharma Details
2.13.2 Cerbios-Pharma Major Business
2.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.13.4 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cerbios-Pharma Recent Developments and Future Plans
2.14 Goodwin Biotechnology
2.14.1 Goodwin Biotechnology Details
2.14.2 Goodwin Biotechnology Major Business
2.14.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Solutions
2.14.4 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Goodwin Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Antibody Drug Conjugates Contract Manufacturing by Company Revenue
3.2.2 Top 3 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2023
3.2.3 Top 6 Antibody Drug Conjugates Contract Manufacturing Players Market Share in 2023
3.3 Antibody Drug Conjugates Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Antibody Drug Conjugates Contract Manufacturing Market: Region Footprint
3.3.2 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2024)
5.2 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
6.2 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
6.3.2 United States Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
6.3.3 Canada Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
6.3.4 Mexico Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
7.2 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country
7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
7.3.2 Germany Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.3 France Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.5 Russia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
7.3.6 Italy Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2019-2030)
8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.3 Japan Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.4 South Korea Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.5 India Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
8.3.7 Australia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
9.2 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
9.3 South America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
9.3.1 South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
9.3.2 Brazil Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
9.3.3 Argentina Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2030)
10.3.2 Turkey Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
10.3.4 UAE Antibody Drug Conjugates Contract Manufacturing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Antibody Drug Conjugates Contract Manufacturing Market Drivers
11.2 Antibody Drug Conjugates Contract Manufacturing Market Restraints
11.3 Antibody Drug Conjugates Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antibody Drug Conjugates Contract Manufacturing Industry Chain
12.2 Antibody Drug Conjugates Contract Manufacturing Upstream Analysis
12.3 Antibody Drug Conjugates Contract Manufacturing Midstream Analysis
12.4 Antibody Drug Conjugates Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 8. Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Lonza Group Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 13. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. Recipharm Company Information, Head Office, and Major Competitors
Table 16. Recipharm Major Business
Table 17. Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 18. Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Recipharm Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 23. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Abbvie Company Information, Head Office, and Major Competitors
Table 26. Abbvie Major Business
Table 27. Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 28. Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Abbvie Recent Developments and Future Plans
Table 30. Piramal Pharma Solutions Company Information, Head Office, and Major Competitors
Table 31. Piramal Pharma Solutions Major Business
Table 32. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 33. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Piramal Pharma Solutions Recent Developments and Future Plans
Table 35. Catalent Company Information, Head Office, and Major Competitors
Table 36. Catalent Major Business
Table 37. Catalent Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 38. Catalent Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Catalent Recent Developments and Future Plans
Table 40. Sterling Pharma Solutions Company Information, Head Office, and Major Competitors
Table 41. Sterling Pharma Solutions Major Business
Table 42. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 43. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sterling Pharma Solutions Recent Developments and Future Plans
Table 45. Curia Company Information, Head Office, and Major Competitors
Table 46. Curia Major Business
Table 47. Curia Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 48. Curia Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Curia Recent Developments and Future Plans
Table 50. Novasep Company Information, Head Office, and Major Competitors
Table 51. Novasep Major Business
Table 52. Novasep Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 53. Novasep Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Novasep Recent Developments and Future Plans
Table 55. Ajinomoto Bio-Pharma Services Company Information, Head Office, and Major Competitors
Table 56. Ajinomoto Bio-Pharma Services Major Business
Table 57. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 58. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
Table 60. BSP Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. BSP Pharmaceuticals Major Business
Table 62. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 63. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. BSP Pharmaceuticals Recent Developments and Future Plans
Table 65. Cerbios-Pharma Company Information, Head Office, and Major Competitors
Table 66. Cerbios-Pharma Major Business
Table 67. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 68. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Cerbios-Pharma Recent Developments and Future Plans
Table 70. Goodwin Biotechnology Company Information, Head Office, and Major Competitors
Table 71. Goodwin Biotechnology Major Business
Table 72. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 73. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Goodwin Biotechnology Recent Developments and Future Plans
Table 75. Global Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million) by Players (2019-2024)
Table 76. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Players (2019-2024)
Table 77. Breakdown of Antibody Drug Conjugates Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Antibody Drug Conjugates Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Antibody Drug Conjugates Contract Manufacturing Players
Table 80. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
Table 81. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
Table 82. Antibody Drug Conjugates Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 83. Antibody Drug Conjugates Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Type (2019-2024)
Table 86. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Type (2025-2030)
Table 87. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024)
Table 88. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Application (2025-2030)
Table 89. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Antibody Drug Conjugates Contract Manufacturing Raw Material
Table 120. Key Suppliers of Antibody Drug Conjugates Contract Manufacturing Raw Materials
Table 1. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 8. Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Lonza Group Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 13. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. Recipharm Company Information, Head Office, and Major Competitors
Table 16. Recipharm Major Business
Table 17. Recipharm Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 18. Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Recipharm Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 23. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Abbvie Company Information, Head Office, and Major Competitors
Table 26. Abbvie Major Business
Table 27. Abbvie Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 28. Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Abbvie Recent Developments and Future Plans
Table 30. Piramal Pharma Solutions Company Information, Head Office, and Major Competitors
Table 31. Piramal Pharma Solutions Major Business
Table 32. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 33. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Piramal Pharma Solutions Recent Developments and Future Plans
Table 35. Catalent Company Information, Head Office, and Major Competitors
Table 36. Catalent Major Business
Table 37. Catalent Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 38. Catalent Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Catalent Recent Developments and Future Plans
Table 40. Sterling Pharma Solutions Company Information, Head Office, and Major Competitors
Table 41. Sterling Pharma Solutions Major Business
Table 42. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 43. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sterling Pharma Solutions Recent Developments and Future Plans
Table 45. Curia Company Information, Head Office, and Major Competitors
Table 46. Curia Major Business
Table 47. Curia Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 48. Curia Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Curia Recent Developments and Future Plans
Table 50. Novasep Company Information, Head Office, and Major Competitors
Table 51. Novasep Major Business
Table 52. Novasep Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 53. Novasep Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Novasep Recent Developments and Future Plans
Table 55. Ajinomoto Bio-Pharma Services Company Information, Head Office, and Major Competitors
Table 56. Ajinomoto Bio-Pharma Services Major Business
Table 57. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 58. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Ajinomoto Bio-Pharma Services Recent Developments and Future Plans
Table 60. BSP Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. BSP Pharmaceuticals Major Business
Table 62. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 63. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. BSP Pharmaceuticals Recent Developments and Future Plans
Table 65. Cerbios-Pharma Company Information, Head Office, and Major Competitors
Table 66. Cerbios-Pharma Major Business
Table 67. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 68. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Cerbios-Pharma Recent Developments and Future Plans
Table 70. Goodwin Biotechnology Company Information, Head Office, and Major Competitors
Table 71. Goodwin Biotechnology Major Business
Table 72. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product and Solutions
Table 73. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Goodwin Biotechnology Recent Developments and Future Plans
Table 75. Global Antibody Drug Conjugates Contract Manufacturing Revenue (USD Million) by Players (2019-2024)
Table 76. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Players (2019-2024)
Table 77. Breakdown of Antibody Drug Conjugates Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Antibody Drug Conjugates Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Antibody Drug Conjugates Contract Manufacturing Players
Table 80. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Type Footprint
Table 81. Antibody Drug Conjugates Contract Manufacturing Market: Company Product Application Footprint
Table 82. Antibody Drug Conjugates Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 83. Antibody Drug Conjugates Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Type (2019-2024)
Table 86. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Type (2025-2030)
Table 87. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024)
Table 88. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Forecast by Application (2025-2030)
Table 89. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Antibody Drug Conjugates Contract Manufacturing Raw Material
Table 120. Key Suppliers of Antibody Drug Conjugates Contract Manufacturing Raw Materials
LIST OF FIGURES
Figure 1. Antibody Drug Conjugates Contract Manufacturing Picture
Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type in 2023
Figure 4. IgG1
Figure 5. IgG4
Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application in 2023
Figure 8. Solid Tumors Picture
Figure 9. Hematological Malignancies Picture
Figure 10. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Antibody Drug Conjugates Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region in 2023
Figure 15. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Players in 2023
Figure 21. Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Antibody Drug Conjugates Contract Manufacturing Market Share in 2023
Figure 23. Global Top 6 Players Antibody Drug Conjugates Contract Manufacturing Market Share in 2023
Figure 24. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Type (2019-2024)
Figure 25. Global Antibody Drug Conjugates Contract Manufacturing Market Share Forecast by Type (2025-2030)
Figure 26. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Application (2019-2024)
Figure 27. Global Antibody Drug Conjugates Contract Manufacturing Market Share Forecast by Application (2025-2030)
Figure 28. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 38. France Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region (2019-2030)
Figure 45. China Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 48. India Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 62. Antibody Drug Conjugates Contract Manufacturing Market Drivers
Figure 63. Antibody Drug Conjugates Contract Manufacturing Market Restraints
Figure 64. Antibody Drug Conjugates Contract Manufacturing Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Antibody Drug Conjugates Contract Manufacturing in 2023
Figure 67. Manufacturing Process Analysis of Antibody Drug Conjugates Contract Manufacturing
Figure 68. Antibody Drug Conjugates Contract Manufacturing Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Antibody Drug Conjugates Contract Manufacturing Picture
Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type in 2023
Figure 4. IgG1
Figure 5. IgG4
Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application in 2023
Figure 8. Solid Tumors Picture
Figure 9. Hematological Malignancies Picture
Figure 10. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Antibody Drug Conjugates Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region in 2023
Figure 15. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Players in 2023
Figure 21. Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Antibody Drug Conjugates Contract Manufacturing Market Share in 2023
Figure 23. Global Top 6 Players Antibody Drug Conjugates Contract Manufacturing Market Share in 2023
Figure 24. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Type (2019-2024)
Figure 25. Global Antibody Drug Conjugates Contract Manufacturing Market Share Forecast by Type (2025-2030)
Figure 26. Global Antibody Drug Conjugates Contract Manufacturing Consumption Value Share by Application (2019-2024)
Figure 27. Global Antibody Drug Conjugates Contract Manufacturing Market Share Forecast by Application (2025-2030)
Figure 28. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 38. France Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Region (2019-2030)
Figure 45. China Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 48. India Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Antibody Drug Conjugates Contract Manufacturing Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Antibody Drug Conjugates Contract Manufacturing Consumption Value (2019-2030) & (USD Million)
Figure 62. Antibody Drug Conjugates Contract Manufacturing Market Drivers
Figure 63. Antibody Drug Conjugates Contract Manufacturing Market Restraints
Figure 64. Antibody Drug Conjugates Contract Manufacturing Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Antibody Drug Conjugates Contract Manufacturing in 2023
Figure 67. Manufacturing Process Analysis of Antibody Drug Conjugates Contract Manufacturing
Figure 68. Antibody Drug Conjugates Contract Manufacturing Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
